ACADIA PHARMACEUTICALS INC (ACAD) Insider Trading

Name: ACADIA PHARMACEUTICALS INC (ACAD) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 7, 2026): Mark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER): Exercise/Conversion of 5,849 shares, $104.3K.

Get alerted when insiders trade ACAD

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta